Kuehn Law Encourages FNA, TGI, AVAV, and NARI Investors to Contact Law Firm

Core Insights - Kuehn Law, PLLC is investigating potential claims related to several proposed mergers, focusing on whether the boards acted to maximize shareholder value, failed to disclose material information, and conducted a fair process [1][2][3]. Group 1: Proposed Mergers - Paragon 28, Inc. has entered into a definitive agreement with Zimmer Biomet Holdings Inc. for $13.00 per share, with the deal expected to close in the first half of 2025, pending shareholder approval and regulatory clearances [1]. - Triumph Group, Inc. has agreed to be acquired by affiliates of Warburg Pincus and Berkshire Partners for $26.00 per share in cash, with the transaction set to close in the second half of 2025 [2]. - AeroVironment, Inc. has entered into a definitive agreement with BlueHalo LLC, where AeroVironment shareholders will own 60.5% and BlueHalo equity holders will hold 39.5% after closing adjustments [2]. - Inari Medical, Inc. has agreed to be acquired by Stryker for $80.00 per share in cash, with the transaction expected to close in Q1 2025 [3]. Group 2: Shareholder Involvement - Kuehn Law emphasizes the importance of shareholder participation in ensuring the integrity and fairness of financial markets, encouraging concerned shareholders to get involved [4]. - The firm covers all case costs and does not charge its investor clients, advising shareholders to act promptly due to the time-sensitive nature of legal rights [4].